PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Create Medic Co., Ltd.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Create Medic Co., Ltd. owes ¥0.18 for every ¥1 it owns. Net profit fell 15% in the year to Dec 2025, and grew 14% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Dec 2025.

P/E ratio

18.4

Investors pay ¥18.4 for every ¥1 of Create Medic Co., Ltd.'s yearly profit, higher than 62% of Healthcare companies in Japan.

P/B ratio

0.54

The share price is 0.54 times Create Medic Co., Ltd.'s book value per share, lower than 96% of Healthcare companies in Japan.

Market cap

¥8.9 B

The total market value of all of Create Medic Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 63% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥16.5 B

What Create Medic Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥2,072

Net worth divided by the number of shares. The share price of ¥1,121 is 0.5 times this, which is the P/B above.

Return on equity (ROE)

3.5%

Create Medic Co., Ltd. earned 3.5% on its shareholders' money over the last year, lower than 66% of Healthcare companies in Japan.

Owes vs Owns

0.18×

Create Medic Co., Ltd. owes ¥0.18 for every ¥1 it owns (low).

Dividend yield

4.29%

Create Medic Co., Ltd. pays 4.29% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in Japan.

Revenue growth

+5%

Revenue rose 5% in the year to Dec 2025, and grew 3% a year on average over 3 years.

Profit growth

-15%

Net profit fell 15% in the year to Dec 2025, and grew 14% a year on average over 3 years.

Profit margin

5.2%

Create Medic Co., Ltd. keeps ¥5 of every ¥100 of revenue as net profit.

Cash quality

0.7×

Cash from Create Medic Co., Ltd.'s business was 0.7× its reported profit in the year to Dec 2025 — less cash came in than the profit reported.

Interest cover

126.9×

Create Medic Co., Ltd.'s operating profit covered its interest costs 126.9 times in the year to Dec 2025.

Cash vs debt

Net cash

Create Medic Co., Ltd. held ¥5.1 B more cash than debt (net cash) at Dec 2025.

Questions

What is Create Medic Co., Ltd.'s P/E ratio?

Investors pay ¥18.4 for every ¥1 of Create Medic Co., Ltd.'s yearly profit, higher than 62% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Create Medic Co., Ltd.: ¥8.9 B ÷ ¥16.5 B (30 Jun 2026) = 0.5.

What is Create Medic Co., Ltd.'s return on equity?

Create Medic Co., Ltd. earned 3.5% on its shareholders' money over the last year, lower than 66% of Healthcare companies in Japan.

How much does Create Medic Co., Ltd. owe compared with what it owns?

Create Medic Co., Ltd. owes ¥0.18 for every ¥1 it owns (low).

Does Create Medic Co., Ltd. pay a dividend?

Yes. Create Medic Co., Ltd. pays 4.29% of its share price as dividends a year, higher than 90% of dividend-paying Healthcare companies in Japan.

Is Create Medic Co., Ltd.'s revenue growing?

Revenue rose 5% in the year to Dec 2025, and grew 3% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.